Michael Weber

Business Angel/ICEBEAR Ventures AG

📍 Germany🔄 Updated September 2026💼 1 investments📅 4 years investing🗓 Last invested Jan 2022
Operator-angel🌍 Germany
1
Total investments
0
Early stage
1
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jan 2022
Connecting veterinarians and pet owners. petleo.net vet.petleo.net
Experience · 4 entries
All (4)
Investments (1)
Founder (3)
2024
Co-Founder, Co-CEO
Nov 2024
Biodiversity deserves more than trust—it deserves proof. And we deliver it. At Biodivertis, we use advanced DNA marker technology to create genetic passports for animals and plants ensuring trust, transparency and traceablity. Our work provides verifiable proof of origin—bringing transparency to supply chains and supporting species conservation. Our innovation empowers protection efforts, prevents fraud, and ensures that certified products truly come from where they claim to. Our platform enables seamless integration for external users—from authorities to industry—offering direct access to origin verification through a secure database. With Biodivertis, we are building a revolutionary bridge between science, technology, and global species conservation. We make identity visible – for a world where authenticity matters. Lets connect! Based in Potsdam, Germany / Active worldwide / Focus: DNA barcoding, eDNA, Species ID
2022
Angel Investor
Jan 2022
Connecting veterinarians and pet owners. petleo.net vet.petleo.net
2017
Co-Founder, Co-CEO
Dec 2017
At MCG Motion Capture GmbH, based in Potsdam, Germany, we dont just track motion - we understand it. We capture motion and translate it into personalized, actionable insights. We specialise in high-precision motion tracking for: - human and veterinary biomechanics - clinical and rehabilitation research by using proprietary, first-in-class sensor technology and translating data into personalized, actionable insights. Empowering people to maintain daily activities and improve quality of life. Lets collaborate!
Co-Founder
Sep 2017
Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood in multiple immune-related disorders.